IGF1 and acromegaly: Up to 99% of patients with acromegaly harbor a pituitary somatotroph adenoma, leading to growth hormone (GH) and Insulin-like growth factor 1 (IGF-I) hypersecretion, resulting in multi-system implications (3, 4).